Author:
Mallepally Niharika,Abu-Sbeih Hamzah,Ahmed Osman,Chen Ellie,Shafi Mehnaz A.,Neelapu Sattva S.,Wang Yinghong
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference24 articles.
1. IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin’s lymphoma;Maloney;Blood,1997
2. Rituximab in the treatment of non-Hodgkin’s lymphoma;Hauptrock;Biologics,2008
3. Impact of rituximab (rituxan) on the treatment of B-cell non-Hodgkin’s lymphoma;Dotan;P T,2010
4. The safety and side effects of monoclonal antibodies;Hansel;Nat Rev Drug Discov,2010
5. Rituximab-induced immunodysregulatory ileocolitis in a patient with follicular lymphoma;Blombery;J Clin Oncol,2011
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献